NADPH → (2R)-1,1,1-trifluoro-2-(4-((2R)-2-(8-oxa-3-azabicyclo[3.2.1]oct-3-ylmethyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol
Reaction equation
[F:1][C:2]([F:36])([F:35])[C@@:3]([C:6]1[CH:11]=[CH:10][C:9]([N:12]2[CH2:17][CH2:16][N:15]([S:18]([C:21]3[S:22][CH:23]=[CH:24][CH:25]=3)(=[O:20])=[O:19])[CH2:14][C@@H:13]2[CH2:26][N:27]2[CH2:33][CH:32]3[O:34][CH:29]([CH2:30][CH2:31]3)[CH2:28]2)=[CH:8][CH:7]=1)([OH:5])[CH3:4].FC(F)(F)[C@](C1C=CC(N2CCN(S(C3SC=CC=3)(=O)=O)C[C@H]2CN2CC3OC(CC3)C2)=CC=1)(O)C.FC(F)(F)[C@](C1C=CC(N2CCN(S(C3SC=CC=3)(=O)=O)C[C@@H]2CN2CC3OC(CC3)C2)=CC=1)(O)C.C1N=C(N)C2N=CN([C@@H]3O[C@H](COP(OP(OC[C@H]4O[C@@H](N5C=C(C(N)=O)CC=C5)[C@H](O)[C@@H]4O)(O)=O)(O)=O)[C@@H](O)[C@H]3OP(O)(O)=O)C=2N=1>>[F:36][C:2]([F:1])([F:35])[C@@:3]([C:6]1[CH:7]=[CH:8][C:9]([N:12]2[CH2:17][CH2:16][N:15]([S:18]([C:21]3[S:22][CH:23]=[CH:24][CH:25]=3)(=[O:19])=[O:20])[CH2:14][C@H:13]2[CH2:26][N:27]2[CH2:33][CH:32]3[O:34][CH:29]([CH2:30][CH2:31]3)[CH2:28]2)=[CH:10][CH:11]=1)([OH:5])[CH3:4]Participants
Procedure
(2R)-1,1,1-trifluoro-2-(4-((2S)-2-(8-oxa-3-azabicyclo[3.2.1]oct-3-ylmethyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol; (2S)-1,1,1-trifluoro-2-(4-((2R)-2-(8-oxa-3-azabicyclo[3.2.1]oct-3-ylmethyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol; (2S)-1,1,1-trifluoro-2-(4-((2S)-2-(8-oxa-3-azabicyclo[3.2.1]oct-3-ylmethyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol. 1H NMR (400 MHz, CD3OD) δ 7.91-7.89 (m, 1H), 7.68-7.66 (m, 1H), 7.47-7.45 (d, J=8.8 Hz, 2H), 7.29-7.17 (m, 1H), 6.93-6.90 (d, J=8.8 Hz, 2H), 4.26-4.20 (m, 2H), 4.11-4.04 (m, 2H), 3.81-3.76 (m, 1H), 3.50-3.45 (m, 1H), 3.26-3.20 (m, 1H), 2.75-2.55 (m, 5H), 2.42-2.39 (m, 1H), 2.28-2.19 (m, 2H), 1.93-1.74 (m, 4H), 1.70 (s, 3H). m/z (ESI, +ve ion) 546.6 (M+H)+. GK-GKRP EC50 (NADPH-coupled)=0.154 μM; GK-GKRP EC50 (LC MS/MS)=0.178 μM.
Sources & evidence
- ORD record
- ord-a4bafb786ef1460ea634d135b2fed538
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08431563B2
Reaction notes
Loading…